Huons Global Co., Ltd. (KOSDAQ:084110)
44,150
-1,900 (-4.13%)
Oct 10, 2025, 3:30 PM KST
Huons Global Revenue
Huons Global had revenue of 212.66B KRW in the quarter ending June 30, 2025, with 1.43% growth. This brings the company's revenue in the last twelve months to 813.69B, up 1.43% year-over-year. In the year 2024, Huons Global had annual revenue of 813.46B with 7.26% growth.
Revenue (ttm)
813.69B
Revenue Growth
+1.43%
P/S Ratio
0.66
Revenue / Employee
6.90B
Employees
118
Market Cap
537.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 813.46B | 55.08B | 7.26% |
Dec 31, 2023 | 758.38B | 94.01B | 14.15% |
Dec 31, 2022 | 664.36B | 89.72B | 15.61% |
Dec 31, 2021 | 574.65B | 51.60B | 9.87% |
Dec 31, 2020 | 523.05B | 73.62B | 16.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
LigaChem Biosciences | 148.28B |